Barrow, Hanley, Mewhinney & Strauss
NEO icon

Barrow, Hanley, Mewhinney & Strauss’s NeoGenomics NEO Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-223
Closed -$1.72K – 397
2025
Q3 		$1.72K Hold
223
– – ﹤0.01% 319
2025
Q2 		$1.63K Buy
+223
New +$1.8K ﹤0.01% 300

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Barrow, Hanley, Mewhinney & Strauss's NEO Position: Q4 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 223 shares — an estimated $1.72K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NEO in Q2 2025 and held it in 2 quarters. The position peaked at $1.72K in Q3 2025. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 223 NeoGenomics shares in Q4 2025, an estimated $1.72K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in NeoGenomics in Q2 2025 and held it in 2 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's NeoGenomics position peaked at $1.72K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2025, filed 11 Feb 2026.